secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aquestive Therapeutics, Inc. (AQST)
CIK:        0001398733
Form:       8-K
Filed at:   2025-06-02T23:59:59+00:00
Accession:  0001628280-25-028813
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aquestive furnishes June 2025 corporate presentation; no specific new data disclosed
--------------------------------------------------------------------------------

- Investor presentation dated June 2025 provided for institutional meetings.
- No financial or operational updates (e.g., revenue, pipeline) are evident from the excerpt.
- Presentation available on company's investors website.
- Filing is a routine Reg FD disclosure, not a material event.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1398733/000162828025028813/0001628280-25-028813-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1398733/000162828025028813/aqst-20250602.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-028813

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer